Company Market Research Report: WISE SpA

Company Overview

• Name: WISE SpA

• Mission: Develop and produce best-in-class leads for neuromonitoring and neuromodulation to advance the treatment of acute and chronic indications.

• Founded: 2011

• Founder: No specific information on founders.

• Key People:

• Luca Ravagnan, Ph.D., MBA - Chief Executive Officer

• Giulia Salzano - Director of Administration and Finance

• Roberto Cuzzupè - Quality Assurance Manager & Head of Regulatory

• Thomas Bianchi - Business Development Manager

• Rodrigo Bianchi, MBA - Chairman of the Board of Directors

• Additional Board Members include Davide Turco and Nicola Trevisan.

• Headquarters: Milan, Italy, and Berlin, Germany.

• Number of Employees: Not specified.

• Revenue: Not specified.

• Known For: Developing implantable leads for neuromonitoring and neuromodulation, utilizing unique stretchable and flexible electrode technology.

Products

WISE Cortical Strip

• Description: A revolutionary electrode for neuromonitoring during brain tumor and epilepsy surgeries.

• Key Features:

• Incredibly thin and conformable design.

• Utilizes stretchable platinum contacts embedded in a soft and thin silicone film.

• Highly ergonomic and conforms to the brain surface.

• Suitable for intraoperative neurophysiological monitoring.

Heron® Lead

• Description: The first expandable percutaneous lead for neuromodulation.

• Key Features:

• Multicolumn paddle lead, expandable for spinal cord stimulation (SCS).

• Combines benefits of paddle leads and cylindrical percutaneous leads.

• Can be implanted percutaneously.

• Capable of better coverage, unidirectional stimulation, higher energy efficiency, and lower migration.

Recent Developments

• New Products Launched:

• The Heron® lead is being developed as the first unidirectional multicolumn lead for spinal cord stimulation that can be implanted percutaneously.

• New Features Added:

• The Heron® lead now combines benefits of both paddle and cylindrical leads, offering enhanced energy efficiency and migration control.

• New Partnerships and Agreements:

• Exclusive distribution agreement with Axontronic GmbH for the WISE Cortical Strip in Germany and Austria.

• Exclusive distribution agreement with Neuroclast Pty Ltd for the WISE Cortical Strip in Australia.

• Exclusive distribution agreement with Soinde Neuro S.L. for the WISE Cortical Strip in Spain.

• Agreement with EB Neuro for distribution in Italy.

• Other Recent Developments:

• Completed a new financing round worth €25 million to accelerate the development of the Heron® lead and commercialization of the WISE Cortical Strip.

• Converted from a Limited Liability Company to a Joint Stock Company (S.p.A.) signaling growth ambitions.

• Appointment of a new Board of Directors with extensive experience in the medtech sector.

• FDA clearance of the WISE Cortical Strip for intraoperative neurophysiological monitoring.

Summary

WISE SpA is a cutting-edge medical device company that stands at the forefront of neuromonitoring and neuromodulation technology. Through their innovative use of flexible, stretchable electrodes, WISE SpA has introduced products like the WISE Cortical Strip and Heron® lead, which promise to revolutionize medical applications, particularly in surgical and therapeutic settings. With strategic global partnerships and significant investments, WISE SpA is positioned to expand its influence and continue its mission of enhancing patient care and advancing neuromodulation treatments.